Test 2 Diabetes Pathophysiology part 2 Flashcards
Q: which is NOT released by the beta-cells of the pancreas?
a. C-peptide
b. Insulin
c. Glucagon
d. Amylin
c. Glucagon
Q: Someone who has good blood glucose control over years is less likely to develop:
a. Retinopathy
b. Peripheral vascular disease
c. Cerebrovascular disease
a. Retinopathy-microvascular (has to do with control of glucose)
Q: What hormone is responsible for increasing blood glucose through promotion of glycogenolysis and gluconeogenesis
a. Insulin
b. GLP-1
c. Amylin
d. Glucagon
d. Glucagon
Non-Pharmacologic Diabetes Treatments
- Non-pharmacological treatments (always recommend)
- Diet—Decrease glucose/insulin spikes
- Well balanced – keep glucose from spiking too much
- Not a lot of processed simple sugars
- Physical activity—Increase glucose utilization and uptake by GLUT4
- Profound effect – significantly increases the level of GLUT4 that is available on cells(transporters that help pull glucose in from circulation)
- Weight Loss – may help to control Type 2 DM
- Diet—Decrease glucose/insulin spikes
Pharmacological Diabetes Treatment
- Insulin
- Sulfonylureas
- Meglitinides
- Biguanides
- Thiazolidinediones
- a-Glucosidase inhibitors
- Incretin mimetics
- Amylin analog
- SGLT2 inhibitor
Normal vs Diabetic Patients
- Normal:
- You eat food, gut absorption of carbohydrates causes postprandial hyperglycemia.
- Gut releases GLP1 and GIP to pancreas (incretin effect)
- helps increase insulin and decreases glucagon
- causes hepatic cells decrease glucose production
- peripheral muscle increases glucose uptake
- adipose tissue increase fat production
- Gut releases GLP1 and GIP to pancreas (incretin effect)
- Diabetes:
- You eat food, gut absorption of carbohydrates causes postprandial hyperglycemia.
- Gut releases about 50% less GLP1 and GIP to pancreas which decreases the incretin effect
- less the help to pancreas to release insulin impairing insulin release
- since insulin release is impaired the glucagon is not as strongly inhibited
- hepatic cells don’t as strongly decrease glucose production
- peripheral muscle have less glucose uptake
- adipose tissue lipolyse fat increasing glucose
- Gut releases about 50% less GLP1 and GIP to pancreas which decreases the incretin effect
Insulin Mechanism
- Insulin
- Required for Type 1 DM
- Also can be given for Type 2 DM (especially later after they’ve had DM for a while)
- Goal of therapy
-
Mimic normal insulin secretion
- Basal (mimics the low pulses→supresses gluconeogenesis)
- Give long-acting to mimic basal
- Prandial/Bolus (mimics insulin after meals-acute response)
- Give short acting to mimic bolus
- Basal (mimics the low pulses→supresses gluconeogenesis)
-
Mimic normal insulin secretion
- Source—recombinant DNA
- human insulin→low allergenicity
- not proinsulin like natural so does NOT increase C-peptide
- Strength—usually 100 units/ml (U-100)
Insulin Preparations differ on:
- Onset (how quickly will insulin peak and drop glucose)
- Duration of action (how long will it be active?)
- Absorption (different absorption rates from injection site vary their onset and DOA)
- Route (SC, IV, intranasal)
Insulin by duration/onset
- Rapid acting (short onset, short duration)
- Glulisine
- Lispro
- Aspart
- Short acting (a bit longer onset and duration)
- Regular
- Intermediate acting (a bit more time til onset, intermediate duration)
- NPH
- Long/Ultra-long acting:
- Detemir
- Glargine
- Degludec
- Ryzodeg (70% degludec + 30% aspart)
Inhaled insulin
- Afrezza—rapid acting insulin (bolus), inhalation use
- Cough, dry mouth, hypoglycemia possible
“Artificial pancreas”
- Medtronic MiniMed670G
- approved September 28, 2016!!! Available in Spring 2017
- Closed loop pump system
- sensors and pumps working together
- has sensors that checks blood glucose every 5 min and adjusts insulin delivery.
- It delivers insulin when needed→high glucose and doesn’t if not no need→low glucose
- Delivers basal insulin only, user must program bolus (prandial) doses based on the carb intake of meal
Insulin Adverse Effects
- Insulin Adverse Effects
-
Hypoglycemia
- confusion, may lose their balance and fall – common in elderly
- due too taking too much insulin or not eating when expected
- Action is independent of glucose in the blood
-
Weight gain
- insulin promotes lipogenesis (fat production) and pulls excess blood glucose into the cells→stored as glycogen and fatty acids)
- Insulin allergy (much less common now-animal is no longer used)
-
Hypoglycemia
Sulfonylureas MOA
- Sulfonylureas
- MOA—increase insulin release from beta-cells in pancreas by closing KATP channels through the sulfonylurea receptor; insulin secretagogues
- Sulfonylureas block ATP-dependent K+ channel →results in insulin release
- Also decreases serum glucagon (an indirect effect mediated via insulin – do not directly affect alpha-cells)
- MOA—increase insulin release from beta-cells in pancreas by closing KATP channels through the sulfonylurea receptor; insulin secretagogues
- Insulin secretion is independent of glucose
- will cause insulin secretion regardless of glucose levels
Sulfonylureas Adverse Effects
- Insulin secretion is independent of glucose
- Risk of hypoglycemia—action is independent of glucose levels
- Similar effect to insulin injections
- Risk of hypoglycemia—action is independent of glucose levels
-
Weight gain
- 1-3 kg (2 – 7 lb – affects the patient’s ability to monitor and regulate their blood sugar)
-
CV mortality increase? (glyburide especially, not very common in others)
- Sulfonylurea receptor present in some amount in cardiac myocytes and vascular smooth muscle – blocking activity at theses sites increases the patient’s risk of CV mortality
Sulfonylurea classes
- First generation—Less potent, more SE – NOT RESPONSIBLE FOR THESE
- Tolbutamide
- Chlorpropamide
- Tolazamide
- Second generation—safer and more commonly used today
- Glyburide
- Most problematic 2nd gen
- Non-hypoglycemic metabolites
- though some metabolites have a mild hypoglycemic effect (although low potency)
- Flushing possible with alcohol use
- Glipizide – has a slightly shorter half-life
- Glimepiride
- Glyburide
- Glipizide and glimepiride have less complications than glyburide